Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.3000 |
Ask | 0.4500 |
Strike | 40.00 |
Expiry date | 2024-10-18 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 155 |
Rocket Pharmaceuticals (RCKT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
CRANBURY, N.J., May 29, 2024--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the European Commission (EC), based on a positive opinion issued by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA), has granted orphan medicinal product designation for RP-A601, the Company’s adeno-associated viru